NEWSROOM | Galderma

#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month

Galderma announces publication of phase 2b trial results demonstrating the rapid and long-lasting benefits of nemolizumab in clinical trial subjects with uncontrolled atopic dermatitis

Unveiling the new Galderma!

Cetaphil® Launches Innovative Digital Campaign to Connect with Millions of Consumers Experiencing Skin Sensitivity

Galderma online survey reveals almost two thirds of rosacea patients* are experiencing worsening of signs and symptoms related to essential COVID-19 mask wearing

Differin® Celebrates Fourth Annual Retinoid Education Week by Offering People with Acne the Chance to “Get Clear” Through Large-Scale Product Giveaway

Galderma continues global growth ambition with Sculptra® (injectable poly-L-lactic acid) re-launch in Europe

Galderma receives FDA approval for Restylane® Defyne for chin augmentation

Galderma Announces Launch of Face for Change Program

Galderma launches Dysport® in China for treatment of glabellar lines

Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study with Azzalure® / Dysport® (abobotulinumtoxinA)

Cetaphil Taps Rachel Brosnahan as Creative Consultant for New “Up Close and Sensitive” Digital Campaign